MENU

VCEL Stock Vericel (VCEL, $38.02) price may climb as it broke lower Bollinger Band on Apr 30, 2025

A.I.dvisor
at Tickeron.com
Loading...
VCEL - Vericel Corp
Bollinger signal
Bullish Trend
Odds of UP Trend
Tickeron
Bollinger signal
Price: $38.02
Daily change: -$1.34 (-3.4%)
Daily volume: 384.8K
Industry: Biotechnology
This price move could be a signal that VCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. A.I.dvisor backtested 36 similar cases where VCEL's price broke its lower Bollinger Band, and of them led to a successful outcome. Odds of Success:

VCEL in upward trend: price may ascend as a result of having broken its lower Bollinger Band on April 30, 2025

VCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where VCEL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VCEL's RSI Indicator exited the oversold zone, of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for VCEL just turned positive on April 14, 2025. Looking at past instances where VCEL's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCEL advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VCEL as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for VCEL moved below the 200-day moving average on April 11, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VCEL entered a downward trend on April 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VCEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.523) is normal, around the industry mean (14.398). P/E Ratio (190.000) is within average values for comparable stocks, (63.545). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.855). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (8.278) is also within normal values, averaging (252.274).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com